143 related articles for article (PubMed ID: 12446023)
1. Evidence for heterogeneity of T cell expansion in polymyositis and inclusion body myositis.
van der Meulen MF; van Wichen DF; van Blokland WT; van den Berg LH; Wokke JH; Hoogendijk JE; de Weger RA
J Neuroimmunol; 2002 Dec; 133(1-2):198-204. PubMed ID: 12446023
[TBL] [Abstract][Full Text] [Related]
2. Inclusion body myositis: clonal expansions of muscle-infiltrating T cells persist over time.
Müntzing K; Lindberg C; Moslemi AR; Oldfors A
Scand J Immunol; 2003 Aug; 58(2):195-200. PubMed ID: 12869141
[TBL] [Abstract][Full Text] [Related]
3. Plasma cells in muscle in inclusion body myositis and polymyositis.
Greenberg SA; Bradshaw EM; Pinkus JL; Pinkus GS; Burleson T; Due B; Bregoli L; O'Connor KC; Amato AA
Neurology; 2005 Dec; 65(11):1782-7. PubMed ID: 16344523
[TBL] [Abstract][Full Text] [Related]
4. Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies.
Amemiya K; Granger RP; Dalakas MC
Brain; 2000 Oct; 123 ( Pt 10)():2030-9. PubMed ID: 11004120
[TBL] [Abstract][Full Text] [Related]
5. Myeloid dendritic cells in inclusion-body myositis and polymyositis.
Greenberg SA; Pinkus GS; Amato AA; Pinkus JL
Muscle Nerve; 2007 Jan; 35(1):17-23. PubMed ID: 16969836
[TBL] [Abstract][Full Text] [Related]
6. Expanded T cell receptor Vβ-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells.
Pandya JM; Fasth AE; Zong M; Arnardottir S; Dani L; Lindroos E; Malmström V; Lundberg IE
Arthritis Rheum; 2010 Nov; 62(11):3457-66. PubMed ID: 20662057
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis.
Salajegheh M; Rakocevic G; Raju R; Shatunov A; Goldfarb LG; Dalakas MC
Neurology; 2007 Oct; 69(17):1672-9. PubMed ID: 17954782
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis of primary inflammatory myopathies].
Benveniste O; Squier W; Boyer O; Hilton-Jones D; Herson S
Presse Med; 2004 Nov; 33(20):1444-50. PubMed ID: 15611679
[TBL] [Abstract][Full Text] [Related]
9. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
[TBL] [Abstract][Full Text] [Related]
10. Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature.
Papadimas GK; Kokkinis C; Xirou S; Chrysanthou M; Kararizou E; Papadopoulos C
Rheumatol Int; 2019 Aug; 39(8):1459-1466. PubMed ID: 31055642
[TBL] [Abstract][Full Text] [Related]
11. Morphologic and Molecular Patterns of Polymyositis With Mitochondrial Pathology and Inclusion Body Myositis.
Kleefeld F; Uruha A; Schänzer A; Nishimura A; Roos A; Schneider U; Goebel HH; Schuelke M; Hahn K; Preusse C; Stenzel W
Neurology; 2022 Nov; 99(20):e2212-e2222. PubMed ID: 36195449
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
Dalakas MC
Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
[TBL] [Abstract][Full Text] [Related]
13. Invasive fibroblasts: fundamental difference between sporadic inclusion body myositis and polymyositis.
Doppler K; Pantazis G; Mack A; Bornemann A
Muscle Nerve; 2014 Feb; 49(2):175-80. PubMed ID: 23649793
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Choi YC; Dalakas MC
Neurology; 2000 Jan; 54(1):65-71. PubMed ID: 10636127
[TBL] [Abstract][Full Text] [Related]
15. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
Chahin N; Engel AG
Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
[TBL] [Abstract][Full Text] [Related]
16. Polymyositis: an overdiagnosed entity.
van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M
Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190
[TBL] [Abstract][Full Text] [Related]
17. T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.
Hiniker A; Daniels BH; Margeta M
J Neuropathol Exp Neurol; 2016 Mar; 75(3):239-45. PubMed ID: 26843609
[TBL] [Abstract][Full Text] [Related]
18. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalization of FAS and FAS ligand in inflammatory myopathies.
De Bleecker JL; Meire VI; Van Walleghem IE; Groessens IM; Schröder JM
Acta Neuropathol; 2001 Jun; 101(6):572-8. PubMed ID: 11515785
[TBL] [Abstract][Full Text] [Related]
20. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
